Week Ending August 2, 2021

An Inside Look at Disparities in Lung Cancer Care for At-Risk Populations
“On World Lung Cancer Day, we explore current guidelines for lung cancer screening in the United States, implications of the COVID-19 pandemic, and disparities in mortality and access to care by race and socioeconomic status.”

Rios Reviews Advances in NSCLC for World Lung Cancer Day
“In an interview with Targeted Oncology, Jorge A. Rios, MD, discusses recent advanced in NSCLC and the role targeted and immune checkpoint inhibitor therapy has played in this progress.”

Precision Medicine is Changing Lung Cancer Treatment, But More Studies are Needed
“In an interview with Targeted Oncology™, Robert Coleman, MD, discussed the evolving treatment paradigm of lung cancer and the role of molecular testing now and in the future.”

Unconventional Candidate For a Lung Cancer Hero
“In 2018, at the height of his Wall Street career, at the age of 32, and with a wife and two young daughters to support, Marty Keiser made a life-changing decision to walk away from everything and go all in on what he believed to be the early innings of a bio revolution.”

The Impact of Immunotherapy Use in Small Cell Lung Cancer
“During a Targeted Oncology Case-Based Roundtable event, Jarushka Naidoo, MB, BCh, MHS. discussed the case of a 73-year-old patient with small cell lung cancer who first presented with shortness of breath, productive cough, chest pain, and fatigue.”

Lung cancer survivor, former Panthers player and Raleigh nonprofit work to change perceptions about lung cancer

Moffitt Researchers Identify New Relevant Target for PARP Inhibitor Talazoparib

ASCO Lung Cancer Targeted Therapy Data Expands EGFR and MET